Scala Biodesign
We provide a unique one-shot computational solution to accelerate the development of proteins into commercial products.
We provide a unique one-shot computational solution to accelerate the development of proteins into commercial products.
Scala Biodesign is a biotechnology startup based in Israel that aims to revolutionize the development of proteins into commercial products. Their slogan "We provide a unique one-shot computational solution to accelerate the development of proteins into commercial products" encapsulates their mission. Founded in 2022, the company has already attracted substantial investment. In their latest funding round, which took place on 11 September 2023, Scala Biodesign secured a notable $5.50M in a Seed Round investment. This investment came from Intel Capital and TLV Partners. Scala Biodesign's innovative technology harnesses evolutionary analysis, atomistic protein design calculations, and AI to design proteins with superior properties. This has significant implications for the pharmaceutical, chemical, and sustainability industries, enabling the accelerated development of commercial products.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $5.50M | 2 |
|
11 Sep 2023 |
| Non Equity Assistance | Unknown | 1 |
|
09 Nov 2022 |
No recent news or press coverage available for Scala Biodesign.
We care about your data, and we'd love to use cookies make your experience better.
